Iannone Robert 4

What Happened

• Robert Iannone, EVP, Global Head of R&D & Chief Medical Officer at Jazz Pharmaceuticals (JAZZ), had 6,209 shares withheld to satisfy tax obligations tied to the vesting of previously granted restricted stock units. The shares were valued at $188.69 each, totaling approximately $1,171,576. This disposition (code F) reflects tax withholding, not an open-market sale.

Key Details

• Transaction date: 2026-03-05; Filing date: 2026-03-09.
• Shares involved: 6,209 shares withheld at $188.69 per share; total value ≈ $1,171,576.
• Transaction code: F — shares withheld to cover tax obligations from RSU vesting (footnote confirms withholding).
• Shares owned after transaction: not specified in the provided filing excerpt.
• No 10b5-1 plan or late-filing flag noted in the supplied information.

Context

• Tax-withholding dispositions are routine administrative actions when restricted stock units vest; they are not equivalent to a deliberate open-market sale and generally shouldn’t be read as a directional insider trade signal.